Clinical Trial Update: Intradetrusor Onabotulinumtoxin A (Botox) at the Time of Transurethral Resection of the Prostate or Transurethral Waterjet Ablation of the Prostate for Mixed Lower Urinary Tract Symptoms

View source ↗

Summary

A clinical trial is recruiting to evaluate intradetrusor injections of onabotulinumtoxinA (Botox) at the time of transurethral resection of the prostate (TURP) …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Lower Urinary Tract Symptoms

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Benaroya Research Institute | Conditions: Benign Prostatic Hypertrophy (BPH), Lower Urinary Track Symptoms | Status: RECRUITING